Clear-cell porocarcinoma: Another cutaneous marker of diabetes mellitus

American Journal of Dermatopathology

Volumn 19, Issue 5, 1997, Pages 540-544

  Requena, Luis ^a,b   Sarasa, José Luis ^a   Piqué, Enric ^a   Fariña, Ma Carmen ^a   Olivares, Mercedes ^a   Martín, Lucia ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b NONE   (Spain)

Author keywords

Clear cell porocarcinoma; Diabetes mellitus; Neoplasm

Indexed keywords

PHOSPHORYLASE;

AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CLEAR CELL POROCARCINOMA; DIABETES MELLITUS; DISEASE ASSOCIATION; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN DISEASE;

ACROSPIROMA, ECCRINE; AGED; CA-15-3 ANTIGEN; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; CYTOPLASMIC GRANULES; DIABETES MELLITUS, TYPE 2; ECCRINE GLANDS; GLYCOGEN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROVILLI; PHOSPHORYLASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030731368     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199710000-00110     Document Type: Article

References (19)

1. Abenoza P, Ackerman AB. Porocarcinomas. In: Abenoza P, Ackerman AB, eds. Neoplasms with eccrine differentiation, Philadelphia: Lea & Febiger; 1990:415-31.
2. Pinkus H, Mehregan AH. Epidermotropic eccrine carcinoma: a case combining features of eccrine poroma and Paget's dermatosis. Arch Dermatol 1963;88:597-607.
3. Bottles K, Sagebiel R, McNutt NS, et al. Malignant eccrine poroma: case report and review of the literature. Cancer 1984;53:1579-85.
4. Shaw M, McKee P, Lowe D, Black MM. Malignant eccrine poroma: a study of 27 cases. Br J Dermatol 1982;107:675-80.
5. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: a clinicopathologic study of 35 cases. Arch Dermatol 1983;119:104-14.
6. Snow SN, Reizner GT. Eccrine porocarcinoma of the face. J Am Acad Dermatol 1992;27:306-11.
7. Headington JT, Koski J, Murphy PJ. Clear cell glyecogenesis in multiple syringomas. Arch Dermatol 1972;106:353-6.
8. Diestelmeier MR, Rodmon OG. Eruptive generalized clear cell syringomas. Arch Dermatol 1983;119:927-9.
9. Furue M, Hori Y, Nakabayashi Y. Clear-cell syringoma: association with diabetes mellitus. Am J Dermatopathol 1984;6:131-8.
10. Fiebelman CE, Maize JC, Clear cell syringoma: a study by conventional and electron microscopy. Am J Dermatopathol 1984;6:139-50.
11. Ambrojo P, Requena L, Aguilar A, Sánchez Yus E, Furio V. Clearcell syringoma: immunohistochemistry and electron microscopy study. Dermatologica 1989;178:164-6.
12. Kitaraura K, Muraki R, Tamura N. Clear-cell syringoma. Cutis 1983;32:169-72.
13. Kudo H, Yonezawa I, Ieki A, Miyachi Y. Generalized eruptive clear-cell syringoma. Arch Dermatol 1989;125:1716-17.
14. Saitoh A, Ohtake N, Fukuda S, Tamaki K. Clear cells of eccrine glands in a patient with clear cell syringoma associated with diabetes mellitus. Am J Dermatopathol 1993;15:166-8.
15. Freeman RG, Knox JUM, Spiller WF. Eccrine poroma. Am J Clin Pathol 1961;36:444-50.
16. Stalmans W, Laloux M, Hers HG. The interaction of liver phosphorylase with glucose and AMP. Eur J Biochem 1974;49:415-27.
17. Holyoke JB, Lobitz WC. Histologic variations in the structure of human eccrine sweat glands. J Invest Dermatol 1952;18:147-67.
18. Burket JM, Brooks R, Burket DA. Eccrine gland clear reticulated cytoplasm. J Am Acad Dermatol 1985;13:497-500.
19. Abenoza P, Ackerman AB. Histologic features in eccrine units. In: Abenoza P, Ackerman AB, eds. Neoplasms with eccrine differentiation Philadelphia: Lea & Febiger: 1990:45-72.